 JPMorgan Chase Co. trimmed its holdings in NGM Biopharmaceuticals NYSE:NGM by 14.7 in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 243,442 shares of the companys stock after selling 41,823 shares during the quarter. JPMorgan Chase Co. owned about 0.36 of NGM Biopharmaceuticals worth 3,001,000 ... 